Xencor reported $-32759000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amgen AMGN:US USD 2.14B 826M
Arrowhead Research ARWR:US USD -85511000 13.46M
AstraZeneca AZN:LN USD 1.64B 1.28B
Biogen BIIB:US USD 1.13B 76.7M
Bristol Myers Squibb BMY:US USD 1.61B 185M
Cytokinetics CYTK:US USD -142310000 122.49M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Johnson & Johnson JNJ:US USD 4.46B 356M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Macrogenics MGNX:US USD -24813000 16.49M
Merk MRK:US USD 3.25B 696M
Novartis NOVN:VX USD 1.57B 121M
Pfizer PFE:US USD 8.61B 1.3B
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Roche Holding ROG:VX 8.53B 2.4B
Seattle Genetics SGEN:US USD -190816000 55.99M
Xencor XNCR:US USD -32759000 1.22M